REFERENCES

[1] “History of Vaccines - A Vaccine History Project of The College of Physicians of

Philadelphia | History of Vaccines,” https://www.historyofvaccines.org/

[2] A. Boylston, “The origins of inoculation,” J. R. Soc. Med., vol. 105, no. 7, p. 309,

Jul. 2012, doi: 10.1258/JRSM.2012.12K044

[3] M. R. Hilleman, “Vaccines in historic evolution and perspective: A narrative of

vaccine discoveries,” Vaccine, vol. 18, no. 15, pp. 1436–1447, Feb. 2000, doi: 10.1

016/S0264-410X(99)00434-X

[4] G. L. Geison, “The private science of Louis Pasteur,” Priv. Sci. Louis Pasteur, vol.

306, pp. 22–50, Dec. 1996, doi: 10.1515/9781400864089/HTML

[5] “Pasteur International Network association | Institut Pasteur,” https://www.pasteur.

fr/en/international/pasteur-international-network-association

[6] P. Deville, Plague and Cholera, 2014.

[7] J. B. Ulmer, U. Valley, and R. Rappuoli, “Vaccine manufacturing: Challenges and

solutions,” Nat. Biotechnol., vol. 24, pp. 1377–1383, 2006, doi: 10.1038/nbt1261

[8] “GPEI – Global Polio Eradication Initiative,” https://polioeradication.org/

[9] M. Roser, H. Ritchie, and B. Dadonaite, “Child and Infant Mortality,” “ https://

ourworldindata.org/child-mortality,” 2013.

[10] M. C. Flickinger, “Encyclopedia of biotechnology: Bioprocess, bioseparation, and

cell technology. Chapter: Viral vaccine production in cell culture (John Aunins),”

pp. 7 zv. (XXVII, 5051 str.) TS-WorldCat T4-Biop, 2010.

[11] “Vaccines Licensed for Use in the United States | FDA,” https://www.fda.gov/

vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states

[12] “Global Vaccine Market Report Overview of MI4A,” 2018, Accessed: Nov. 08,

2021. [Online]. Available: http://who.int/immunization/MI4A

[13] M. Kaddar, “Global Vaccine Market Features and Trends,” https://www.who.int/

influenza_vaccines_plan/resources/session_10_kaddar.pdf, 2013.

[14] “Vaccines Market | Including & Excluding COVID-19 vaccines | Global Forecast to

2026,” https://www.marketsandmarkets.com/Market-Reports/vaccine-technologies-

market-1155.html?gclid=CjwKCAiA78aNBhAlEiwA7B76p3fHFVjr3dO5EaXlxFj-

m0mxqxkiGyuX5k3QX6pOk14HpuSc4P8KZbxoCBjEQAvD_BwE

[15] “Vaccines Market Size, Share, Growth | Global Industry Report [2027],” https://

www.fortunebusinessinsights.com/industry-reports/vaccines-market-101769

[16] P. Health Ontario, “At a Glance: Vaccine regulatory process in Canada 1 AT A

GLANCE Vaccine Regulatory Process in Canada.”

[17] Y. Gu, X. Zhao, and X. Song, “Ex vivo pulsed dendritic cell vaccination against

cancer,” Acta Pharmacol. Sin. 2020 417, vol. 41, no. 7, pp. 959–969, May 2020,

doi: 10.1038/s41401-020-0415-5

[18] E. Sparrow et al., “Global production capacity of seasonal and pandemic influenza

vaccines in 2019,” Vaccine, vol. 39, no. 3, pp. 512–520, Jan. 2021, doi: 10.1016/

J.VACCINE.2020.12.018

[19] “General Principles for the Development of Vaccines to Protect Against Global

Infectious Diseases | FDA,” https://www.fda.gov/regulatory-information/search-

fda-guidance-documents/general-principles-development-vaccines-protect-against-

global-infectious-diseases

[20] E. S. Langer and R. A. Rader, “Biopharmaceutical Manufacturing is Shifting to

Single-Use Systems. Are the Dinosaurs, the Large Stainless Steel Facilities,

Becoming Extinct? | American Pharmaceutical Review – The Review of

American Pharmaceutical Business & Technology,” BioPlan Associates Inc,

2018. https://www.americanpharmaceuticalreview.com/Featured-Articles/

14

Bioprocessing of Viral Vaccines